MedTrace Logo

Brady MX a Quality Improvement Study

NCT02976181 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2019-09-19

Study results available
· View outcomes & findings →

Summary

Medtronic is sponsoring a quality improvement study called Brady MX. It is hypothesized that lack of awareness of treatment and diagnostics pathways result in lower number of referrals to implanters of IPG.

Conditions

  • Sinus Node Disfunction

Interventions

DEVICE

IPG

Patient might require IPG device to be implanted under standard of care

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02976181 on ClinicalTrials.gov